SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-044984
Filing Date
2011-05-05
Accepted
2011-05-04 21:20:48
Documents
11
Period of Report
2011-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q c15615e10vq.htm 10-Q 640513
2 EX-31.1 c15615exv31w1.htm EX-31.1 5970
3 EX-31.2 c15615exv31w2.htm EX-31.2 6014
4 EX-32.1 c15615exv32w1.htm EX-32.1 2403
5 EX-32.2 c15615exv32w2.htm EX-32.2 2473
  Complete submission text file 0000950123-11-044984.txt   7938962

Data Files

Seq Description Document Type Size
6 EX-101 INSTANCE DOCUMENT celg-20110331.xml EX-101.INS 920951
7 EX-101 SCHEMA DOCUMENT celg-20110331.xsd EX-101.SCH 82648
8 EX-101 CALCULATION LINKBASE DOCUMENT celg-20110331_cal.xml EX-101.CAL 83393
9 EX-101 LABELS LINKBASE DOCUMENT celg-20110331_lab.xml EX-101.LAB 632017
10 EX-101 PRESENTATION LINKBASE DOCUMENT celg-20110331_pre.xml EX-101.PRE 376725
11 EX-101 DEFINITION LINKBASE DOCUMENT celg-20110331_def.xml EX-101.DEF 200222
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34912 | Film No.: 11812206
SIC: 2834 Pharmaceutical Preparations